1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. BMX Kinase

BMX Kinase (BMX激酶)

Bmx is a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Bmx is characterized by an N-terminal pleckstrin homology domain and has been shown to be a downstream effector of phosphatidylinositol 3-kinase. P21-activated kinase 1 (Pak1), another well characterized effector of phosphatidylinositol 3-kinase, has been implicated in the progression of breast cancer cells.

BMX Kinase 相关产品 (4):

目录号 产品名 作用方式 纯度
  • HY-80002
    BMX-IN-1 Inhibitor 99.04%
    BMX-IN-1是BMX 激酶IC50 值为8.0 nM。
  • HY-101267
    CHMFL-BMX-078 Inhibitor ≥98.0%
    CHMFL-BMX-078是高效的,选择性的,不可逆的,类型II BMX激酶抑制剂,IC50值为11 nM。
  • HY-109010
    Poseltinib Inhibitor 98.01%
    Poseltinib 是一种具有口服活性,选择性,不可逆的小分子Bruton酪氨酸激酶 (BTK) 抑制剂,IC50 为 1.95 nM,对 BMX,TEC 和 TXK 的选择性作用分别是 0.3,2.3 和 2.4 倍。Poseltinib可共价结合 BTK 的活性位点 (半胱氨酸 481 残基),同时有效抑制 B 细胞受体 (BCR),Fc受体 (FcR),Toll样受体 (TLR) 介导的信号传导。
  • HY-101522
    CHMFL-EGFR-202 Inhibitor
    CHMFL-EGFR-202 是一种有效、不可逆的表皮生长因子受体 (EGFR) 突变型激酶抑制剂, 对 耐药突变型 EGFR T790M 和 WT EGFR 激酶作用的 IC50 值分别为 5.3 nM 和 8.3 nM。在细胞中,CHMFL-EGFR-202 对 EGFR L858R/T790M 的选择性是 EGFR 野生型的 10 倍。CHMFL-EGFR-202 以 “DFG-in-C-helix-out” 的不活跃结合构象形式共价结合 EGFR,对 EGFR 突变体驱动的非小细胞肺癌 (NSCLC) 细胞株具有较强的抗增殖作用。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.